By proceeding, you agree to our Terms of Use and Privacy Policy.
Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.
10-12 May 2022
Following the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer, 2021, Roche’s newly opened pRED Innovation Center in Basel, and exciting data from Recce Pharma’s anti-infective candidate using organoids, the 7th Annual 3D Tissu
Event Ended
USA
Paid
Boston
12-14 July 2022
From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models – Deepen Our Understanding of Tumor Biology, Resistance Mechanisms & Dosing Strategy Following the success of KRAS, HER2, BCMA, drug developers ha
29-30 September 2022
Gain valuable insights into the approaches impacting the immunotherapy field through 40+ outstanding presentations tackling key discussion points in immuno-oncology, immunology and inflammation.Benefits to Attending... Gain a forward-looking perspect
UK
London
01-01 December 2022
With the expansion of Oncology and Immuno-Oncology drug development, effective preclinical platforms are required for testing efficacy and safety of new targets.
Netherlands
Free
Leiden
24-26 January 2023
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.
San Francisco